Clinical Trials
Chemo +/- INCB161734 in previously untreated KRAS G12D mutated metastatic pancreatic adenocarcinom
Disease Type: Pancreatic
A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Locations
Alleghany , Blacksburg , Roanoke , Salem , Wytheville